A genetic predictive model for precision treatment of diffuse large B-cell lymphoma with early progression
Early progression after the first-line R-CHOP treatment leads to a very dismal outcome and necessitates alternative treatment for patients with diffuse large B-cell lymphoma (DLBCL). This study aimed to develo...
8:33
Biomarker Research 2020
No hay comentarios:
Publicar un comentario